Laboratory of Cell Biology, Institute of Biomedical Chemistry, Moscow 119121, Russia.
Department for Biomedical Technologies and Tissue Engineering, Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow 123182, Russia.
Int J Mol Sci. 2024 May 23;25(11):5695. doi: 10.3390/ijms25115695.
Articular cartilage damage still remains a major problem in orthopedical surgery. The development of tissue engineering techniques such as autologous chondrocyte implantation is a promising way to improve clinical outcomes. On the other hand, the clinical application of autologous chondrocytes has considerable limitations. Mesenchymal stromal cells (MSCs) from various tissues have been shown to possess chondrogenic differentiation potential, although to different degrees. In the present study, we assessed the alterations in chondrogenesis-related gene transcription rates and extracellular matrix deposition levels before and after the chondrogenic differentiation of MSCs in a 3D spheroid culture. MSCs were obtained from three different tissues: umbilical cord Wharton's jelly (WJMSC-Wharton's jelly mesenchymal stromal cells), adipose tissue (ATMSC-adipose tissue mesenchymal stromal cells), and the dental pulp of deciduous teeth (SHEDs-stem cells from human exfoliated deciduous teeth). Monolayer MSC cultures served as baseline controls. Newly formed 3D spheroids composed of MSCs previously grown in 2D cultures were precultured for 2 days in growth medium, and then, chondrogenic differentiation was induced by maintaining them in the TGF-β1-containing medium for 21 days. Among the MSC types studied, WJMSCs showed the most similarities with primary chondrocytes in terms of the upregulation of cartilage-specific gene expression. Interestingly, such upregulation occurred to some extent in all 3D spheroids, even prior to the addition of TGF-β1. These results confirm that the potential of Wharton's jelly is on par with adipose tissue as a valuable cell source for cartilage engineering applications as well as for the treatment of osteoarthritis. The 3D spheroid environment on its own acts as a trigger for the chondrogenic differentiation of MSCs.
关节软骨损伤仍然是矫形外科的一个主要问题。组织工程技术的发展,如自体软骨细胞移植,是改善临床疗效的一种有前途的方法。另一方面,自体软骨细胞的临床应用有相当大的局限性。来自不同组织的间充质基质细胞(MSCs)已被证明具有软骨分化潜能,尽管程度不同。在本研究中,我们评估了 MSC 在 3D 球体培养中软骨分化前后与软骨形成相关的基因转录率和细胞外基质沉积水平的变化。MSCs 来自三种不同的组织:脐带华通氏胶(WJMSC-华通氏胶间充质基质细胞)、脂肪组织(ATMSC-脂肪组织间充质基质细胞)和乳牙牙髓(SHEDs-人脱落乳牙牙髓干细胞)。单层 MSC 培养作为基线对照。由先前在 2D 培养中生长的 MSC 组成的新形成的 3D 球体在生长培养基中预培养 2 天,然后通过在含有 TGF-β1 的培养基中维持 21 天来诱导软骨分化。在所研究的 MSC 类型中,WJMSCs 在软骨特异性基因表达的上调方面与原代软骨细胞最为相似。有趣的是,这种上调在所有 3D 球体中都在一定程度上发生,甚至在添加 TGF-β1 之前就已经发生。这些结果证实,华通氏胶的潜力与脂肪组织相当,是软骨工程应用以及治疗骨关节炎的有价值的细胞来源。3D 球体环境本身就可以作为 MSC 软骨分化的触发因素。